Skip to content

A population-based, multicenter cohort study of combined screening for gastrointestinal tumors

A population-based, multicenter cohort study of combined screening for gastrointestinal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071999
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive disease

Interventions

Group one‘s control( relative of group one ):None
group two :None
group two's control( relative of group two):None

Sponsors

National Clinical Research Center for Digestive Diseases/The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects were 45 to 70 years old when enrolled 2. Willing and able to sign informed consent

Exclusion criteria

Exclusion criteria: 1. History of any type of malignancy 2. Previous resection of esophagus, stomach or colorectal 3. Received gastrointestinal endoscopy such as colonoscopy and gastroscopy in recent 5 years 4. Have received fecal occult blood test and fecal DNA test in the past 1 year. 5. Contraindications to endoscopy. 6. Warning symptoms of digestive tract tumors, including: (1) Difficulty swallowing, choking or halting feeling when eating recently (2) Recent esophageal foreign body sensation or swallowing pain (3) Recent long-term loss of appetite and appetite (4) Recent and prolonged symptoms of indigestion (including acid reflux, heartburn, abdominal grumbling, burping, nausea or premature satiety, etc.) (5) Recent symptoms of abdominal mass, abdominal pain, vomiting or hematemesis (6) It was medically diagnosed as iron deficiency anemia (7) Recent changes in hematochezia, black stool or stool character and frequency (8) Recent symptoms of perianal discomfort (including soreness, itching, lumps, prolapse or other discomfort) (9) Unexplained weight loss (more than 10% of base body weight) in the past 6 months Step 7 Get pregnant 8. There are other serious comorbiditions that reduce screening benefits (including severe lung disease, advanced kidney disease, advanced liver disease, severe heart failure, etc.)

Design outcomes

Primary

MeasureTime frame
Gastroscopy;Colonoscopy;FIT;Detection of Helicobacter pylori (HP) antigen;SEPT9 gene methylation detection;RNF180 gene methylation detection;

Countries

China

Contacts

Public ContactKaichun Wu

The First Affiliated Hospital of Air Force Military Medical University

zhengrong4956@163.com+86 137 0921 8743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026